Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study
Sign Up to like & getrecommendations! Published in 2020 at "Haemophilia"
DOI: 10.1111/hae.14215
Abstract: European regulatory authorities request postmarketing safety and efficacy data for factor IX (FIX) products. read more here.
Keywords: alfa treatment; efficacy nonacog; safety efficacy; safety ... See more keywords